3 Penny Stocks to Add to Your January 2021 Watchlist
As we kick off the first full trading day of the year for penny stocks and blue chips, there is a lot for investors to look forward to. While it is difficult to assume what the year will look like as a whole, many investors are excited about the future of trading penny stocks.
In 2021, we saw the S&P 500 hit several all-time highs, mixed in with a sizable amount of volatility. And because of this, trading stocks has not been easy, to say the least. With the Omicron variant still wreaking havoc on world markets, now is the time to cement your trading strategy to stay up to date with the present state of the market.
During 2022, many traders expect bullishness as the variant could also signal the end of the pandemic. However, there is a lot that is up in the air right now. So, if you’re making a penny stocks watchlist, there is a lot to keep track of. But, with the right strategy and a thorough understanding of how to trade, making money with penny stocks in 2022 can be doable. Considering all of this, let’s take a look at three penny stocks for your January watchlist.
3 Penny Stocks to Watch in January 2021
- Immix Biopharma Inc. (NASDAQ: IMMX)
- Creative Medical Technology Holdings Inc. (NASDAQ: CELZ)
- Polarityte Inc. (NASDAQ: PTE)
Immix Biopharma Inc. (NASDAQ: IMMX)
One of the largest gainers of the day so far is IMMX stock. By morning trading, shares of IMMX had pushed up by almost 120% to $7.70. This brings its five-day gain to over 140%, which is no small feat.
While many gains like this occur with penny stocks without any news, an exciting announcement came out during premarket trading for IMMX stock. Today, the company stated that it received a U.S. FDA designation for its leading product candidate known as IMX-110. IMX-110 is used in the treatment of pediatric cancer, which is a devastating ailment with a high unmet clinical need.
“We are pleased by FDA’s acknowledgment of the urgent need for a safe and effective treatment for children with this devastating disease. We are encouraged by our Phase 1b/2a clinical data in soft tissue sarcoma.”The CEO of Immix, Ilya Rachman
This is big news for the company and could help to get this drug on the way to commercialization. With any biotech company, news from the FDA is always the most important catalyst to growth. And while this is not a full approval, this is a big step in the right direction. Considering this, will IMMX stock be on your list of penny stocks to watch?
Creative Medical Technology Holdings Inc. (NASDAQ: CELZ)
Another major gainer of the day so far is CELZ stock, shooting up by a very respectable, 56%. This brings its five-day gain to over 60% despite a 6-month loss of almost 80%. So, is this bullish sentiment with CELZ stock here to stay? To understand this, we have to take a closer look at the company.
While there was no news today that sparked this gain, we can look at some of its most recent announcements to see why shares are shooting up. In November of 2021, the company announced a 1-500 reverse stock split. The goal with this is to offer both liquidity and more volume as it uplisted to the NASDAQ Capital Market.
If you’re not familiar, Creative Medical Technology is a biotech penny stock working on regenerative medicine and stem-cell tech. It does these in fields such as immunotherapy, urology, neurology, and more. While this price action is impressive, it’s also crucial to take it with a grain of salt. As we saw today, shares of CELZ stock are highly volatile. And because of this, understanding what the company does and why it’s moving is important. So, whether CELZ is worth buying or not is up to you.
Polarityte Inc. (NASDAQ: PTE)
Polarityte Inc. is a penny stock that we’ve covered numerous times in the past few months. And with a 17% gain during morning trading, PTE stock is once again on investors’ radars. In the past five days, PTE stock has shot up by a staggering 70%. The most recent news from the biotech company came a few weeks ago when it announced the submission of a complete response to the FDA. This complete response regards its SkinTE IND application.
“I am incredibly proud of the extraordinary efforts of our entire team in preparing our complete response to the Agency. We believe that our response is robust and compelling in terms of addressing the issues raised by the FDA. We cannot predict how the Agency will respond or whether the IND will be accepted based on our complete response, but we look forward to receiving the Agency’s feedback in due course.”Richard Hague, the CEO and President of Polarityte
The SkinTE is a product used in the potential treatment of chronic cutaneous ulcers. Right now, it is working on developing the clinical profile for this, which involves chemistry, manufacturing and control or CMC. While the timeline moving forward is not set in stone, this is an exciting prospect nevertheless. With all of that in mind, do you think PTE stock is worth adding to your penny stocks watchlist in 2022?
Which Penny Stocks Are You Watching Right Now?
With a new year upon us, now is the time to find the best penny stocks to buy. And although it can seem difficult due to the sheer number of factors impacting the stock market right now, it is by no means impossible.
With the right research and a commitment to understanding how penny stocks trade, making money with small caps can be entirely possible. But, knowing who you are as a trader and what is going on in the market will both be crucial to your strategy. With all of that in mind, which penny stocks are you watching right now?
If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!